Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Dermatology

Journal Scan / Research · February 11, 2021

Secukinumab Appears Effective and Safe for Children With Severe Chronic Plaque Psoriasis

Journal of the European Academy of Dermatology and Venereology: JEADV


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of the European Academy of Dermatology and Venereology: JEADV
Secukinumab Demonstrates High Efficacy and a Favourable Safety Profile in Paediatric Patients With Severe Chronic Plaque Psoriasis: 52-Week Results From a Phase 3 Double-Blind Randomized, Controlled Trial
J Eur Acad Dermatol Venereol 2020 Oct 17;[EPub Ahead of Print], C Bodemer, A Kaszuba, K Kingo, A Tsianakas, A Morita, E Rivas, P Papanastasiou, D Keefe, M Patekar, P Charef, L Zhang, S Cafoncelli, C Papavassilis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading